Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Copenhagen Stock Exchange  >  Novo Nordisk A/S    NOVO.B   DK0060534915

SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
Latest news on NOVO NORDISK A/S
09/01 Insulin infusion device maker CeQur raises $100 million
09/01 NOVO NORDISK A/S : Share repurchase programme
08/31 NOVO NORDISK A/S : A/S : - Share repurchase programme
08/30 NOVO NORDISK A/S : EDITORIAL: Will we invest in ourselves to create jobs?
08/28 Investors still in the dark as cyber threat grows
08/27 NOVO NORDISK A/S : Patent Issued for Automatic Injection Device with a Top Relea..
08/27 NOVO NORDISK A/S : Study Findings from Novo Nordisk Provide New Insights into Pe..
08/27 NOVO NORDISK A/S : Patent Issued for Medical Device with Value Sensor (USPTO 910..
08/27 NOVO NORDISK A/S : Pharmaceutical company to bring 700 jobs to Johnston County
08/27DJNOVO NORDISK A/S : to Buy 2 Private US Research Companies for Undisclosed Sum
08/27 NOVO NORDISK A/S : Effective obesity management: It's more than reducing numbers..
08/27DJNOVO NORDISK A/S : Invests $2 Billion to Increase Production
08/27 EMISPHERE TECHNOLOGIES : Highlights Eligen Licensee Novo Nordisk's Entry Into Ph..
08/26 NOVO NORDISK A/S : Pharma firm Novo Nordisk plans new plants for diabetes drugs ..
08/26 NOVO NORDISK A/S : adding diabetes drug output in NC, Denmark
08/26 NOVO NORDISK A/S : to build new Clayton plant; create 691 jobs
08/26 NOVO NORDISK A/S : to initiate phase 3a development of oral semaglutide, a once-..
08/26 NOVO NORDISK A/S : Governor McCrory Announces Nearly 700 New Jobs in Johnston Co..
08/26 NOVO NORDISK A/S : plans 2 billion US dollar investment in new production facili..
08/25 NOVO NORDISK A/S : completes second and final phase 3a trial with liraglutide as..
08/25 NOVO NORDISK A/S : completes second and final phase 3a trial with liraglutide as..
08/24 NOVO NORDISK A/S : Share repurchase programme
08/24 NOVO NORDISK A/S : completes second and final phase 3a trial with liraglutide as..
08/24 NOVO NORDISK A/S : A/S : - Share repurchase programme
08/20 NOVO NORDISK A/S : Patent Issued for Electronic Module for Mechanical Medication..
08/20 NOVO NORDISK A/S : Findings from Novo Nordisk Broaden Understanding of Type 1 Di..
08/19DJDrugmaker H. Lundbeck to Cut Staff, Costs
08/18 NOVO NORDISK A/S : National Association of Professional Women Inducts Daye Bexle..
08/18 NOVO NORDISK A/S : Share repurchase programme
08/17 NOVO NORDISK A/S : A/S : - Share repurchase programme
08/14 NOVO NORDISK A/S : Three Bottom Lines - One Mindset
08/14DJGenmab Licences Antibody Development Technology to Novo Nordisk
08/13 Zosano Pharma Reports Second Quarter 2015 Financial Results
08/12 NOVO NORDISK A/S : Investigators at Novo Nordisk Report Findings in Crohn's Dise..
08/12 NOVO NORDISK A/S : New Data from Novo Nordisk Illuminate Findings in Molecular P..
08/12 NOVO NORDISK A/S : New Findings from Novo Nordisk in the Area of Type 2 Diabetes..
08/12 NOVO NORDISK A/S : Trading in Novo Nordisk shares by board members, executives a..
08/12 NOVO NORDISK A/S : Share repurchase programme
08/12 ZOSANO : Pharma Reports Second Quarter 2015 Financial Results
08/10 NOVO NORDISK A/S : A/S : - Share repurchase programme
08/10 NOVO NORDISK A/S : A/S : - Trading in shares by board members, executives and as..
08/10 NOVO NORDISK A/S : Share repurchase programme
08/10 NOVO NORDISK A/S : Share repurchase programme
08/10 NOVO NORDISK A/S : Trading in Novo Nordisk shares by board members, executives a..
08/10 NOVO NORDISK A/S : Trading in Novo Nordisk shares by board members, executives a..
08/07 NOVO NORDISK A/S : increased operating profit in Danish kroner by 57% in the fir..
08/06DJNOVO NORDISK A/S : Lifts Earnings Target as Diabetes Drug Sales Rise
08/06 NOVO NORDISK A/S : lifts full-year profit outlook after strong second quarter
08/06 NOVO NORDISK A/S : increased operating profit in Danish kroner by 57% in the fir..
08/05 NOVO NORDISK A/S : Details Findings in Leukemia (Leukemia inhibitory factor incr..
08/03DJNOVO NORDISK A/S : 2Q 2015 -- Forecast
08/03 NOVO NORDISK A/S : A/S : - Share repurchase programme
08/03 NOVO NORDISK A/S : Share repurchase programme
07/31 NOVO NORDISK A/S : Poorly controlled Type 2 Diabetes is a worldwide problem- Pro..
07/29 NOVO NORDISK A/S : and NBA Legend Dominique Wilkins Launch My Diabetes Dream Tea..
07/27 NOVO NORDISK A/S : A/S : - Share repurchase programme
07/27 NOVO NORDISK A/S : Share repurchase programme
07/25 NOVO NORDISK A/S : appoints new head of IR
07/24 NOVO NORDISK A/S : Appointment Notice - Novo Nordisk Canada Inc.
07/24 NOVO NORDISK A/S : and Legend Dominique Wilkins Kick Off My Diabetes Dream Team ..
07/24 NOVO NORDISK A/S : Appointment Notice - Novo Nordisk Canada
07/22 NOVO NORDISK A/S : Receives FDA Approval for FlexPro® PenMate® for People with G..
07/22 NOVO NORDISK A/S : Findings from Novo Nordisk Provides New Data on Alzheimer Dis..
07/22 NOVO NORDISK A/S : Data from Novo Nordisk Provide New Insights into Clinical Tri..
07/22 NOVO NORDISK A/S : Researchers from Novo Nordisk Detail Findings in Obesity (Sav..
07/21 NOVO NORDISK A/S : Share repurchase programme
07/20 NOVO NORDISK A/S : A/S : - Share repurchase programme
07/16 NOVO NORDISK A/S : IndyCar racer Charlie Kimball making visit at Hy-Vee
07/15 NOVO NORDISK A/S : Study Findings on Immunoglobulins Are Outlined in Reports fro..
07/13 NOVO NORDISK A/S : Share repurchase programme
07/13 NOVO NORDISK A/S : A/S : - Share repurchase programme
07/13 NOVO NORDISK A/S : Share repurchase programme
07/11 NOVO NORDISK A/S : successfully completes first phase 3a trial with semaglutide ..
07/10 NOVO NORDISK A/S : successfully completes first phase 3a trial with semaglutide ..
07/08 NOVO NORDISK A/S : Findings on Hematology Research Reported by Researchers at No..
1  2  3  4  5  6  7  8  9  10Next
Advertisement
Chart
Duration : Period :
Novo Nordisk A/S Technical Analysis Chart | NOVO.B | DK0060534915 | 4-Traders
Income Statement Evolution
More Financials